Helephar SRL
Helephar reported total assets of 55,332 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Apr 2026).
The score of Helephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Helephar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Apr 2026
- Year ended 31 Dec 2024filed on 29 Apr 2025
Helephar's financial analysis
- Solvency62.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Helephar
Helephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1005.996.896
- VAT number
- BE1005996896
- Peppol
- Registered · 0208:1005996896 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Feb 2024
- Registered office
- 8750 Wingene
- Latest accounts
- 2025 · filed on 08 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Helephar (SRL) has been based in Wingene since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 21,919 € and equity of 34,399 €; its revenue is not published. Its solvency stands at 62.2%, above the median of its sector (44.2%).
Companies similar to Helephar
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- Itipharma Ghyselen Retail sale of pharmaceutical products Soignies · balance sheet 61,934 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
- MGS Pharma Retail sale of pharmaceutical products Stavelot · balance sheet 68,803 €
- Tilosa Retail sale of pharmaceutical products Lokeren · balance sheet 70,195 €
- NT Farma Retail sale of pharmaceutical products Mouscron · balance sheet 56,255 €
- VAN Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
Frequently asked questions about Helephar
What is the revenue of Helephar?
Helephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Helephar?
In Belgium, the VAT number is the company number prefixed with BE: BE1005996896 for Helephar, if the company is VAT-registered. Its company number (CBE) is 1005.996.896.
Where is the registered office of Helephar?
According to the CBE register, the registered office of Helephar is in 8750 Wingene.
What is the equity of Helephar?
At the close of the 2025 financial year, the equity of Helephar amounts to 34,399 €, a solvency of 62.2% of total assets.
Who manages Helephar?
The register lists 1 active mandates at Helephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Helephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →